Cart
sales@molnova.com
Octanoic acid
CAS No. 95809-78-2
Octanoic acid( CPI-613 )
Catalog No. M16844 CAS No. 95809-78-2
CPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 101 | In Stock |
|
| 50MG | 129 | In Stock |
|
| 100MG | 170 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOctanoic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism.
-
DescriptionCPI-613, a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase, disrupts tumor cell mitochondrial metabolism. Phase 2.
-
In Vitro——
-
In Vivo——
-
SynonymsCPI-613
-
PathwayMetabolic Enzyme/Protease
-
TargetDehydrogenase
-
Recptorα-ketoglutarate dehydrogenase| PDH
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number95809-78-2
-
Formula Weight388.59
-
Molecular FormulaC22H28O2S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:78 mg/mL (200.72 mM); Ethanol:78 mg/mL (200.72 mM); Water:<1 mg/mL (<1 mM)
-
SMILESO=C(O)CCCCC(SCC1=CC=CC=C1)CCSCC2=CC=CC=C2
-
Chemical Name6,8-bis(benzylthio)octanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zachar Z, et al. J Mol Med (Berl). 2011, 89(11), 1137-1148.
molnova catalog
related products
-
DHODH-IN-17
DHODH-IN-17 is a human DHODH inhibitor with an IC50 of 0.40 μM. DHODH-IN-17 is a 2- anilino nicotinic acid that can be used in the study of acute myeloid leukemia (AML).
-
Trilostane
Trilostane is an inhibitor of 3 beta-hydroxysteroid dehydrogenase used in the treatment of Cushing's syndrome.
-
Olorofim
Olorofim（F-901318）is a novel selective antifungal compound targeting pyrimidine biosynthesis in mycobacteria, with inhibitory effect on Aspergillus fumigatus DHODH (IC50: 44 nM).
